Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

C-MAC Video Stylet vs. Video Endoscope

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03749837
Recruitment Status : Recruiting
First Posted : November 21, 2018
Last Update Posted : February 3, 2021
Sponsor:
Information provided by (Responsible Party):
University Hospital Inselspital, Berne

Brief Summary:
The purpose of the study is to compare first attempt success rates and time until intubation to establish the learning curves of the participating anaesthesiologists with two different intubation strategies: (Karl Storz C-MAC VS (Video Stylet) and the standard flexible intubation video endoscope at the study site.

Condition or disease Intervention/treatment Phase
Intubation Device: C- MAC VS Device: Video Endoscope Not Applicable

Detailed Description:

The intubation of the trachea is a crucial procedure in anaesthesia and emergency medicine, therefore it is considered as one of the core competences in these disciplines. Novices in the field need to learn intubation fast and without harming patients to ensure a patent airway if needed.

According to the European Union of Medical Specialists (U.E.M.S., 1050 Brussels, BE), every anaesthesiologist has to master different techniques for the airway management. One is the fiberoptic intubation in awake or asleep patients, to manage a difficult airway. For further training, these core competences need to be extended during the career, from level A (has knowledge) to level D (teaches or supervises others). As the intubation with flexible fiberoptic scopes is the gold standard for the management of a known difficult airway, the investigators want to compare this to a new technique. The use of flexible scopes do not guarantee easy intubation in every difficult airway situation and intubation sometimes is difficult to achieve and requires high proficiency (unability to steer, unability to overcome an anatomical obstacle). Various approaches were introduced by the medical device industry to overcome that problem. One new device is a rigid video stylet with a flexible tip (Karl Storz C-MAC VS), which is an advancement of the older rigid scope "Bonfils" (Karl Storz).

Intubation training with the Bonfils stylet has been shown to require about 20 consecutive tracheal intubations by novices to reach expert time. Learning curves for fiberoptic intubations seem to be similar, but a greater variance was observed. A study of the investigators research-group (unpublished data, KEK 247/09), comparing learning curves between the rigid fiberoptic Bonfils and the semi-rigid fiberoptic SensaScope suggested a 90% success rate for intubation within 60 seconds after about 15 trials (Bonfils) and 20 trials (SensaScope). In comparison, there is no validated data for the use of rigid scopes with flexible tips, as these tool are very new.

Video stylets are tools originally designed for difficult airway management as well. The C-MAC VS combines rigid and semi-rigid abilities. Intubation seems to become very easy. But yet, there is no data available which proves that assumption. Thus the study wants to evaluate if intubation success and time is superior with the C-MAC Video Scope compared to the difficult intubation gold standard, the intubation with a standard flexible fiberoptic scope.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 30 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Is a Rigid Fiberscope With a Flexible Tip Superior to Standard Flexible Fiberoptic Intubation: a Prospective Multicentre Randomised Controlled Trial
Actual Study Start Date : December 15, 2018
Estimated Primary Completion Date : October 1, 2022
Estimated Study Completion Date : December 1, 2022

Arm Intervention/treatment
Experimental: C- MAC VS
Intubation with C- MAC VS
Device: C- MAC VS
The C-MAC VS is a new device on the airway management aid market. It will be used according to the instructions of the distributor. Before the study starts on humans, each study participants will do at least 5 intubations on an airway manikin or more until he or she feels confident to use the device.

Active Comparator: Video Endoscope
Intubation with standard fiberoptic scope
Device: Video Endoscope
Fiberoptic video endoscopic devices are standard aids to facilitate intubation on all study sites and are used according to the instructions to use. To facilitate fiberoptic intubation a macintosh blade to raise the root of tongue will be used. Also with these devices the study participants need at least 5 trials to intubate a manikin (or more to feel confident) before they are going to use the study device in patients.




Primary Outcome Measures :
  1. Time (seconds) to successful orotracheal intubation during the first successful attempt. [ Time Frame: Start: Device passes patients lips; End: Device is completely removed out of the tracheal tube (a trial consists of a maximum of 2 intubation attempts, each with a maximum duration of 120 seconds) ]
    With the C-MAC VS and the standard flexible scope


Secondary Outcome Measures :
  1. Overall time from startpoint to glottic view [ Time Frame: It cannot be longer than 240 seconds and is defined for unsuccessful trials, i.e. if no intubation was established, as 360 seconds. ]
    The overall time is defined as the total time to glottic view, summarized over all attempts.

  2. Time to first end expiratory CO2 reading [ Time Frame: Start: Device passes patients lips; End: First end expiratory CO2 reading (trial in total not >240 seconds) ]
    After the airway is secured the first end expiratory CO2 is shown.The investigators will use the standard non-invasive monitoring of the University Hospital to measure the end expiratory CO2

  3. Number of intubation attempts [ Time Frame: Start: Device passes patients lips; End: Device is completely removed out of the tracheal tube (trial in total not >240 seconds) ]
    End of an attempt defined as: device has to be completely removed out of the patient's airway.

  4. Subjective difficulty of the intubation procedure [ Time Frame: Start: Device passes patients lips; End: Device is completely removed out of the tracheal tube (trial in total not >240 seconds ]
    The VAS- Visual analogue scale (score 1-10) is used. It is a measurement instrument for subjective characteristics that cannot be directly measured. Therefore numbers are used to evaluate.

  5. Cormack/Lehane grade [ Time Frame: Start: Device passes patients lips; End: Device is completely removed out of the tracheal tube (trial in total not >240 seconds) ]
    The Cormack/Lehane grade is used to describe the laryngeal view during laryngoscopy. It is rated by the supervisor.

  6. Limited or restricted vision through the devices (either C MAC VS or a standard flexible scope) [ Time Frame: Start: Device passes patients lips; End: Device is completely removed out of the tracheal tube (trial in total not >240 seconds) ]
    The view can be clear or blurred.

  7. Correlation to patients' anatomical characteristics [ Time Frame: Start: Device passes patients lips; End: Device is completely removed out of the tracheal tube (trial in total not >240 seconds) ]
    To assess the influence of difficulty with the airway

  8. Patients vital parameter such as heart rate, during the intubation attempt [ Time Frame: Start: Device passes patients lips; End: Device is completely removed out of the tracheal tube (trial in total not >240 seconds) ]
    The investigators will use the standard non-invasive monitoring of the University Hospital to measure the heart rate.

  9. Patients vital parameter such as blood pressure, during the intubation attempt [ Time Frame: Start: Device passes patients lips; End: Device is completely removed out of the tracheal tube (trial in total not >240 seconds) ]
    The investigators will use the standard non-invasive monitoring of the University Hospital to measure the blood pressure (in millimeters of mercury)

  10. Patients vital parameter such as oxygen saturation, during the intubation attempt [ Time Frame: Start: Device passes patients lips; End: Device is completely removed out of the tracheal tube (trial in total not >240 seconds) ]
    The investigators will use the standard non-invasive monitoring of the University Hospital to measure the oxygen saturation (SpO2 in percent).

  11. Participants characteristics and demographic data [ Time Frame: Before the study session starts (up to 24 hours before the first intubation attempt) ]
    Basic demographic data (including years of experience in anaesthesia).

  12. Patients demographic data such as height [ Time Frame: During the process of screening, up to 24 hours before the study session starts ]
    The size of each patient will be presented in meter/centimeter

  13. Patients demographic data such as weight [ Time Frame: During the process of screening, up to 24 hours before the study session starts ]
    The weight of each patient will be presented in kilograms

  14. Patients demographic data such as ASA risc classification (ASA= American Society of Anaesthesiologists) [ Time Frame: During the process of screening, up to 24 hours before the study session starts ]
    The ASA grading system is used to evaluate the degree of a patient's physical state before selecting the anesthetic or before performing surgery.

  15. Patients demographic data such as age [ Time Frame: During the process of screening, up to 24 hours before the study session starts ]
    The age of each patient will be presented in years.

  16. Patients demographic data such as gender [ Time Frame: During the process of screening, up to 24 hours before the study session starts ]
    The gender of each patient will be presented in female or male.


Other Outcome Measures:
  1. Incidence of injuries due to intubation attempts [ Time Frame: Follow-Up on the first post anaesthesia day (maximum 24 hours post anaesthesia) ]
    Dental damage, mucosal damage, hoarseness, sore throat, swallowing disorders

  2. How often a "hand over to specialist" happens [ Time Frame: Start: Device passes patients lips; End: Device is completely removed out of the tracheal tube (trial in total not >240 seconds) ]
    The device has to be handed over to the supervisor



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Anaesthesiologists starting in the respective anaesthesia department who are not experienced with tracheal intubation with the study devices
  • Informed Consent as documented by signature (Appendix Informed Consent Form)
  • Novice to the C-MAC VS
  • No/few fiberoptic oral asleep intubation experience (max. 5x during the last year)

Exclusion Criteria:

  • More than 5 uses during the past year of either one of the study devices
  • Not available at the study site during entire study (expected drop outs)
  • Not able to fill out English case reports
  • Patients: Planned delayed extubation (e.g. planned transfer to ICU)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03749837


Contacts
Layout table for location contacts
Contact: Robert Greif, Prof., M.D. + 41-31-632-1629 Robert.Greif@insel.ch
Contact: Lorenz Theiler, Prof., M.D + 41-31-632-0804 lorenz.theiler@insel.ch

Locations
Layout table for location information
Canada, Ontario
LHSC / St. Joesephs Not yet recruiting
London, Ontario, Canada
Contact: Rüdiger Noppens, MD, PHD         
Spain
Miguel Servet University Hospital Not yet recruiting
Zaragoza, Spain
Contact: Guillermo I. Perez Navarro, MD, PHD         
Switzerland
Inselspital, Bern University Hospital Recruiting
Bern, Switzerland, 3010
Contact: Robert Greif, Prof., MD    0041316322111    robert.greif@insel.ch   
Contact: Lorenz G Theiler, Prof., MD    0041316322111    loren.theiler@insel.ch   
Sponsors and Collaborators
University Hospital Inselspital, Berne
Investigators
Layout table for investigator information
Principal Investigator: Lorenz Theiler, Prof., M.D Department of Anaesthesiology and Pain Therapy
Publications:
Layout table for additonal information
Responsible Party: University Hospital Inselspital, Berne
ClinicalTrials.gov Identifier: NCT03749837    
Other Study ID Numbers: 2018-00629
First Posted: November 21, 2018    Key Record Dates
Last Update Posted: February 3, 2021
Last Verified: February 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No